| Immunopharmacogenomics: mechanisms of HLA‐associated drug reactions P Deshpande, RJ Hertzman, AM Palubinsky, JB Giles, JH Karnes, ... Clinical Pharmacology & Therapeutics 110 (3), 607-615, 2021 | 49 | 2021 |
| Genetic admixture and survival in diverse populations with pulmonary arterial hypertension JH Karnes, HW Wiener, TH Schwantes-An, B Natarajan, AJ Sweatt, ... American journal of respiratory and critical care medicine 201 (11), 1407-1415, 2020 | 25 | 2020 |
| Machine learning for prediction of stable warfarin dose in US Latinos and Latin Americans HE Steiner, JB Giles, HK Patterson, J Feng, N El Rouby, K Claudio, ... Frontiers in Pharmacology 12, 749786, 2021 | 16 | 2021 |
| Role of the gut microbiome in cardiovascular drug response: The potential for clinical application HE Steiner, K Gee, J Giles, H Knight, BL Hurwitz, JH Karnes Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 42 (2 …, 2022 | 15 | 2022 |
| ABO O blood group as a risk factor for platelet reactivity in heparin-induced thrombocytopenia JH Karnes, J Rollin, JB Giles, KL Martinez, HE Steiner, CM Shaffer, ... Blood, The Journal of the American Society of Hematology 140 (3), 274-284, 2022 | 14 | 2022 |
| Genome-wide association study of platelet factor 4/heparin antibodies in heparin-induced thrombocytopenia JB Giles, HE Steiner, J Rollin, CM Shaffer, Y Momozawa, T Mushiroda, ... Blood Advances 6 (14), 4137-4146, 2022 | 9 | 2022 |
| Prediction of Water Distributions and Displacement at Protein–Ligand Interfaces N Morningstar-Kywi, K Wang, TR Asbell, Z Wang, JB Giles, J Lai, D Brill, ... Journal of Chemical Information and Modeling 62 (6), 1489-1497, 2022 | 6 | 2022 |
| Bringing pharmacomicrobiomics to the clinic through well‐designed studies HE Steiner, HK Patterson, JB Giles, JH Karnes Clinical and Translational Science 15 (10), 2303-2315, 2022 | 5 | 2022 |
| Elucidation of cellular contributions to heparin-induced thrombocytopenia using omic approaches JB Giles, EC Miller, HE Steiner, JH Karnes Frontiers in Pharmacology 12, 812830, 2022 | 5 | 2022 |
| Disparities in ABO blood type determination across diverse ancestries: a systematic review and validation in the All of Us Research Program KL Martinez, A Klein, JR Martin, CU Sampson, JB Giles, ML Beck, ... Journal of the American Medical Informatics Association 31 (12), 3022-3031, 2024 | 2 | 2024 |
| Genome-wide association study identifies variation in ABO as risk factor for platelet reactivity in heparin-induced thrombocytopenia JB Giles, J Rollin, CM Shaffer, HE Steiner, Y Momozawa, I Stanaway, ... Blood 136, 38-39, 2020 | 2 | 2020 |
| Laboratory and demographic predictors of functional assay positive status in suspected heparin-induced thrombocytopenia: A multicenter retrospective cohort study JB Giles, J Rollin, KL Martinez, K Selleng, T Thiele, C Pouplard, ... Thrombosis research 229, 198-208, 2023 | 1 | 2023 |
| PharmGKB summary: heparin-induced thrombocytopenia pathway, adverse drug reaction E Miller, C Norwood, JB Giles, R Huddart, JH Karnes, M Whirl-Carrillo, ... Pharmacogenetics and genomics 32 (3), 117-124, 2022 | 1 | 2022 |
| WaterAlignment: Identification of displaced water molecules in molecular docking using Jonker and Volgenant shortest path augmentation for linear assignment D Brill, JB Giles, IS Haworth, A Nakano Computer Physics Communications 244, 324-328, 2019 | 1 | 2019 |
| Association of Metal Cations with the Anti-PF4/Heparin Antibody Response in Heparin-Induced Thrombocytopenia JB Giles, KL Martinez, HE Steiner, A Klein, A Ooi, J Pryor, N Sweitzer, ... Cardiovascular Toxicology 24 (9), 968-981, 2024 | | 2024 |
| Local Ancestry‐Informed Candidate Pathway Analysis of Warfarin Stable Dose in Latino Populations HE Steiner, KC Carrion, JB Giles, AR Lima, K Yee, X Sun, LH Cavallari, ... Clinical Pharmacology & Therapeutics 113 (3), 680-691, 2023 | | 2023 |
| Genetic, Demographic and Laboratory Predictors of Anti-PF4/Heparin Antibody Response in Heparin-Induced Thrombocytopenia JB Giles The University of Arizona, 2023 | | 2023 |
| Appendix A-Bringing Pharmacomicrobiomics to the Clinic Through Well-Designed Studies HE Steiner, HK Patterson, JB Giles, JH Karnes Increasing Inclusion of Participants, Leveraging Gut Microbiomes, and …, 2022 | | 2022 |
| Appendix C-Machine Learning for Prediction of Stable Warfarin Dose in US Latinos and Latin Americans HE Steiner, JB Giles, HK Patterson, J Feng, N El Rouby, K Claudio, ... Increasing Inclusion of Participants, Leveraging Gut Microbiomes, and …, 2022 | | 2022 |
| Machine Learning for Prediction of Stable Warfarin Dose in US Latinos and Latin Americans. Front. Pharmacol. 12: 749786. doi: 10.3389/fphar. 2021.749786 HE Steiner, JB Giles, HK Patterson, J Feng, N El Rouby, K Claudio, ... Frontiers in Pharmacology| www. frontiersin. org 12, 2021 | | 2021 |
Jason H KarnesUniversity of ArizonaПідтверджена електронна адреса в pharmacy.arizona.edu
